Schizophrenia News and Research

Latest Schizophrenia News and Research

Study opens possibility for creating animal models of memory disorders

If you ask a rat whether it knows how it came to acquire a certain coveted piece of chocolate, Indiana University neuroscientists conclude, the answer is a resounding, "Yes." A study newly published in the journal Current Biology offers the first evidence of source memory in a nonhuman animal.

27 Feb 2013

Natalizumab may be second-line option for pediatric MS patients

Natalizumab may be an effective and well tolerated second-line treatment for pediatric patients with highly active relapsing-remitting multiple sclerosis, say researchers.

26 Feb 2013

Cardiometabolic risk prevention opportunity in early schizophrenia

esearchers have found that cardiometabolic risk in patients with schizophrenia is heightened in those with established disease, suggesting a need for early intervention in those presenting with their first episode.

26 Feb 2013

Research roundup: Patients hesitant to focus on costs; Increase in primary care demand is uneven

One way to contain health care spending is to get patients involved in weighing costs of treatment options with their doctors. Researchers recruited 211 medically insured participants to assess their willingness to consider costs when choosing treatments. The authors found that participants generally "preferred better care, even when the relative benefit it offered was marginal, and even when told that the second-best choice still met the threshold of 'good enough' care from a clinician's perspective.

26 Feb 2013

Mental health risk increased in children with atopic dermatitis

Results from a US study suggest that children with atopic dermatitis (AD) are at significantly increased risk for mental health disorders.

25 Feb 2013

Visual processing clue to schizophrenia risk

An element of the event-related potential response to visual stimuli is impaired in patients with prodromal symptoms of schizophrenia, research suggests.

25 Feb 2013

Protamine–heparin complex antibodies raise concerns

Almost a third of patients treated with protamine for heparin reversal during cardiopulmonary bypass develop antibodies to circulating protamine–heparin complexes, study findings suggest.

25 Feb 2013

Kaposi’s sarcoma risk factors revealed

Scientists have uncovered an intriguing relationship between the risk for Kaposi’s sarcoma, smoking, and the use of highly active antiretroviral therapy.

25 Feb 2013

People with increased genetic risk of schizophrenia more likely to have lower IQs at age 70

People who are at greater genetic risk of schizophrenia are more likely to see a fall in IQ as they age, even if they do not develop the condition. Scientists at the University of Edinburgh say the findings could lead to new research into how different genes for schizophrenia affect brain function over time.

22 Feb 2013

Special issue highlights new research into HIT projects for quality improvement

The Veterans Health Administration (VHA) is aiming to become a leader in using health information technology (HIT) to change the way patients experience medical care, to decrease medical mistakes, and to improve health outcomes.

21 Feb 2013

Policymakers, insurers should consider generic-only coverage to improve health and reduce costs

A new study published online today in the American Journal of Managed Care found that in Medicare Part D, generic drug coverage was cost-saving compared to no coverage in bipolar disorder and schizophrenia, while also improving health outcomes.

21 Feb 2013

Modifiable risk factors found for violence in schizophrenia

Researchers have identified modifiable risk factors for increased violence in people with psychosis that could prove important for risk assessment and management.

20 Feb 2013

Growth in opioid use prompts safety concerns

Prescriptions for opioid drugs have increased significantly in Germany over the past decade, a survey of insurance data has found.

20 Feb 2013

Stanford University neurobiology professor wins Mortimer D. Sackler, M.D. Prize

Columbia University College of Physicians and Surgeons and Weill Cornell Medical College have announced that the Mortimer D. Sackler, M.D. Prize for Distinguished Achievement in Developmental Psychobiology has been awarded to Carla Shatz, PhD, the Sapp Family Provostial Professor in Neurobiology at Stanford University in Palo Alto, California.

20 Feb 2013